The Alzheimer's Association recognizes the need to increase the number of underrepresented clinicians participating in clinical research. We anticipate that by providing this funding opportunity, the number of underrepresented physicians entering and remaining in clinical careers in Alzheimer's and all other dementia will increase.
The areas of research that a clinician scientist proposes for funding through the AACSF-D grant program are not limited to patient-oriented, human subject research, but may also include translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These translational areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies and health services and outcomes research. Disease-related basic science studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
This grant is open to U.S. and international researchers.
Letter of Intent deadline: March 6, 2023; Sep. 6, 2023